Market Cap 311.64M
Revenue (ttm) 213.65M
Net Income (ttm) -38.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18.16%
Debt to Equity Ratio 0.00
Volume 62,800
Avg Vol 69,946
Day's Range N/A - N/A
Shares Out 20.80M
Stochastic %K 82%
Beta 0.81
Analysts Hold
Price Target $12.00

Company Profile

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 353 0 166 99020
Address:
One Central Plaza, 8th Floor 36 Dame Street, Dublin, Ireland
DoMoreCharity
DoMoreCharity Apr. 19 at 12:57 PM
$AMRN Eicosapentaenoic acid ethyl ester, cardiac metabolomic and lipidomic signatures, and cardioprotection in myocardial infarction Published: 17 April 2026 https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag187/8658450
0 · Reply
Family23
Family23 Apr. 19 at 12:13 AM
$AMRN I see that SDL posted this today. Unless I am misreading his comment, how is he a top 10 institutional investor?
2 · Reply
SanDiegoLiving
SanDiegoLiving Apr. 18 at 7:39 PM
$AMRN 🚨 STAY TUNED: NEXT WEEK I’M DROPPING SOMETHING THAT IS MEANT FOR THE ENTIRE ONLINE SHAREHOLDER BASE 🚨 If you’ve been here long enough, then you already know how much time I’ve poured into understanding this company & sharing what I've found over the years. At one point I was spending 30+ hours a week on Amarin alone, because I wanted to thoroughly understand every angle, filing, and signal that would show you guys where the company was headed. That hasn’t changed. Neither has my conviction. Amarin remains my largest holding, & I’ve increased my position drastically over the last few years, elevating me into the top 10 list of institutional shareholders. Next week I’m putting up something that extends beyond the visible posters here. It’s meant for the 30,502 people watching this board, including the ones who read but never post. The timing of this is not accidental, & next week’s post comes at an important moment for this shareholder base heading into the AGM. Stay tuned ⏳
8 · Reply
DoMoreCharity
DoMoreCharity Apr. 18 at 7:46 AM
$AMRN Daryl Wiesen, Jaime Santos, and Willy Jay will host a webinar on April 30 following the Supreme Court’s April 29 oral argument in Hikma v. Amarin. https://www.goodwinlaw.com/en/news-and-events/events/2026/04/practices-hikma-v-amarin-breaking-down-the-supreme-court-argument
0 · Reply
DoMoreCharity
DoMoreCharity Apr. 18 at 4:17 AM
$AMRN Available online 16 April 2026.https://www.sciencedirect.com/science/article/abs/pii/S0939475326002279
0 · Reply
CaptBeer
CaptBeer Apr. 17 at 11:21 PM
BEER GOOD $AMRN GOOD!
1 · Reply
buygreensellredchop
buygreensellredchop Apr. 17 at 8:34 PM
$AMRN Voted no to all but audit... They made money shorting at the expense of retail investors. Shit heads. Any good news is released at stupid hours on weekends. Any bad new monday before Open.. They have this trading sideways deliberately.. cunts..
0 · Reply
SanDiegoLiving
SanDiegoLiving Apr. 17 at 8:26 PM
$AMRN 📞 DIRECT LEEDS OUTREACH, LATER CONFIRMED IN WRITING 📧: EMT2 TIMELINE CLARIFIED A quick reset on the EMT2 timeline now being repeated online: Several weeks ago, I reached out directly to the University of Leeds and obtained the initial timing update by phone. I deliberately held off posting because I wanted written confirmation before putting anything public. That written follow-up recently came in from lead investigator Mark Hull, who confirmed EMT2 is currently in the analysis phase and that the expected window for announcing results remains mid-2026. Just as important, the timing is not locked to a specific conference. Hull explicitly said there is still uncertainty around the precise timing, depending on which conference abstract is submitted to, when the manuscript is ready, and embargo considerations. 📌 So to correct the version now floating around: ❌ October presentation is not confirmed ✅ Analysis is active ✅ June/July is the public results window
2 · Reply
declanaidan
declanaidan Apr. 17 at 7:25 PM
$AMRN Just voted no on everything, except keeping E&Y as auditors. Getting votes in early will give management some urgency before AGM. Since they see how voting is going in real time, this gives them some food for thought over the weekend.
3 · Reply
LMaldague
LMaldague Apr. 17 at 4:55 PM
$AMRN happened on Wednesday. one of our 2039 EU patents prevailed at an opposition hearing. a good step in strengthening our IP
1 · Reply
Latest News on AMRN
Amarin Reports Second Quarter 2025 Financial Results

Jul 30, 2025, 7:00 AM EDT - 9 months ago

Amarin Reports Second Quarter 2025 Financial Results


Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change

Apr 9, 2025, 7:30 AM EDT - 1 year ago

Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change


Amarin Receives National Reimbursement for VAZKEPA® in Italy

Dec 16, 2024, 7:00 AM EST - 1 year ago

Amarin Receives National Reimbursement for VAZKEPA® in Italy


Amarin Appoints Peter Fishman Chief Financial Officer

Dec 13, 2024, 9:00 AM EST - 1 year ago

Amarin Appoints Peter Fishman Chief Financial Officer


Top 3 Health Care Stocks You'll Regret Missing In Q4

Nov 19, 2024, 7:52 AM EST - 1 year ago

Top 3 Health Care Stocks You'll Regret Missing In Q4

SLN TERN


Amarin Board of Directors Announces CEO Transition

Jun 4, 2024, 7:30 AM EDT - 2 years ago

Amarin Board of Directors Announces CEO Transition


Amarin Chairman & CEO Issue Letter to Shareholders

Jan 22, 2024, 7:30 AM EST - 2 years ago

Amarin Chairman & CEO Issue Letter to Shareholders


DoMoreCharity
DoMoreCharity Apr. 19 at 12:57 PM
$AMRN Eicosapentaenoic acid ethyl ester, cardiac metabolomic and lipidomic signatures, and cardioprotection in myocardial infarction Published: 17 April 2026 https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag187/8658450
0 · Reply
Family23
Family23 Apr. 19 at 12:13 AM
$AMRN I see that SDL posted this today. Unless I am misreading his comment, how is he a top 10 institutional investor?
2 · Reply
SanDiegoLiving
SanDiegoLiving Apr. 18 at 7:39 PM
$AMRN 🚨 STAY TUNED: NEXT WEEK I’M DROPPING SOMETHING THAT IS MEANT FOR THE ENTIRE ONLINE SHAREHOLDER BASE 🚨 If you’ve been here long enough, then you already know how much time I’ve poured into understanding this company & sharing what I've found over the years. At one point I was spending 30+ hours a week on Amarin alone, because I wanted to thoroughly understand every angle, filing, and signal that would show you guys where the company was headed. That hasn’t changed. Neither has my conviction. Amarin remains my largest holding, & I’ve increased my position drastically over the last few years, elevating me into the top 10 list of institutional shareholders. Next week I’m putting up something that extends beyond the visible posters here. It’s meant for the 30,502 people watching this board, including the ones who read but never post. The timing of this is not accidental, & next week’s post comes at an important moment for this shareholder base heading into the AGM. Stay tuned ⏳
8 · Reply
DoMoreCharity
DoMoreCharity Apr. 18 at 7:46 AM
$AMRN Daryl Wiesen, Jaime Santos, and Willy Jay will host a webinar on April 30 following the Supreme Court’s April 29 oral argument in Hikma v. Amarin. https://www.goodwinlaw.com/en/news-and-events/events/2026/04/practices-hikma-v-amarin-breaking-down-the-supreme-court-argument
0 · Reply
DoMoreCharity
DoMoreCharity Apr. 18 at 4:17 AM
$AMRN Available online 16 April 2026.https://www.sciencedirect.com/science/article/abs/pii/S0939475326002279
0 · Reply
CaptBeer
CaptBeer Apr. 17 at 11:21 PM
BEER GOOD $AMRN GOOD!
1 · Reply
buygreensellredchop
buygreensellredchop Apr. 17 at 8:34 PM
$AMRN Voted no to all but audit... They made money shorting at the expense of retail investors. Shit heads. Any good news is released at stupid hours on weekends. Any bad new monday before Open.. They have this trading sideways deliberately.. cunts..
0 · Reply
SanDiegoLiving
SanDiegoLiving Apr. 17 at 8:26 PM
$AMRN 📞 DIRECT LEEDS OUTREACH, LATER CONFIRMED IN WRITING 📧: EMT2 TIMELINE CLARIFIED A quick reset on the EMT2 timeline now being repeated online: Several weeks ago, I reached out directly to the University of Leeds and obtained the initial timing update by phone. I deliberately held off posting because I wanted written confirmation before putting anything public. That written follow-up recently came in from lead investigator Mark Hull, who confirmed EMT2 is currently in the analysis phase and that the expected window for announcing results remains mid-2026. Just as important, the timing is not locked to a specific conference. Hull explicitly said there is still uncertainty around the precise timing, depending on which conference abstract is submitted to, when the manuscript is ready, and embargo considerations. 📌 So to correct the version now floating around: ❌ October presentation is not confirmed ✅ Analysis is active ✅ June/July is the public results window
2 · Reply
declanaidan
declanaidan Apr. 17 at 7:25 PM
$AMRN Just voted no on everything, except keeping E&Y as auditors. Getting votes in early will give management some urgency before AGM. Since they see how voting is going in real time, this gives them some food for thought over the weekend.
3 · Reply
LMaldague
LMaldague Apr. 17 at 4:55 PM
$AMRN happened on Wednesday. one of our 2039 EU patents prevailed at an opposition hearing. a good step in strengthening our IP
1 · Reply
Shark2025
Shark2025 Apr. 17 at 2:11 PM
$AMRN DO NOT VOTE YES on anything item except #9, someone needs to audit these MOFO’s……They don’t deserve shit until the stock price is over 70.00…F..K Denner and his minions…..
0 · Reply
DoMoreCharity
DoMoreCharity Apr. 17 at 2:08 AM
$AMRN https://fintel.io/ss/us/amrn
1 · Reply
bennfine
bennfine Apr. 16 at 8:00 PM
$AMRN volume??? Hmmm
0 · Reply
nUme22
nUme22 Apr. 16 at 7:59 PM
$AMRN fish oil never getting sold .. ever
0 · Reply
yevrag
yevrag Apr. 16 at 7:13 PM
$AMRN what a pile off dog shit this stock and company is! These fucking losers have the balls to ask for more shares and more authority!! If retail votes for this then everyone deserves to be right here we should send a loud and clear message. FUCK YOU DENNER BOARD and MANAGEMENT.
0 · Reply
StockHunter75
StockHunter75 Apr. 16 at 5:50 PM
$AMRN need 170 to get my money back from this reverse split scam.
0 · Reply
revivedfossil
revivedfossil Apr. 16 at 5:35 PM
$AMRN weirdness....the pop yeserday and the poop today on higher volume.
1 · Reply
DoMoreCharity
DoMoreCharity Apr. 16 at 4:37 PM
$AMRN https://writtendescription.blogspot.com/2026/04/hikma-v-amarin-argument-preview.html?m=1 https://www.linkedin.com/posts/lisalarrimoreouellette_hikma-v-amarin-argument-preview-activity-7450292458401386496-WnhM?utm_source=share&utm_medium=member_ios&rcm=ACoAAAappXEBEo5xWglK2bmEx478x0aaRWW4o7I
0 · Reply
Novo1
Novo1 Apr. 16 at 3:37 PM
$AMRN man, talk about falling off the cliff. This is a cliff dive without a chute😵‍💫
1 · Reply
biffermeister
biffermeister Apr. 16 at 3:24 PM
$AMRN still amusing as the STOCKholm syndrome plays out. new people take up the cheer leading torch as others say "lordy lordy why did i buy this nightmare".
1 · Reply
SanDiegoLiving
SanDiegoLiving Apr. 15 at 8:38 PM
$AMRN I've been in touch directly with the company, looks like they are fixing it right now, its been taken down 👈😎 Great sign to see them quickly taking action 💪💪💪
4 · Reply
declanaidan
declanaidan Apr. 15 at 8:05 PM
$AMRN Close @ HOD on good volume👍 Happy tax day (because as Amarin shareholders we have no capital gains to pay) 🥴
2 · Reply